<info type="DiseaseOrPhenotypicFeature">Leukemia inhibitory factor</info> protects the <info type="OrganismTaxon">lung</info> during <info type="DiseaseOrPhenotypicFeature">respiratory syncytial viral infection</info>.

<info type="DiseaseOrPhenotypicFeature">BACKGROUND</info>: <info type="DiseaseOrPhenotypicFeature">Respiratory syncytial virus</info> (<info type="ChemicalEntity">RSV</info>) infects the <info type="OrganismTaxon">lung epithelium</info> where it stimulates the production of numerous host <info type="GeneOrGeneProduct">cytokines</info> that are associated with <info type="DiseaseOrPhenotypicFeature">disease burden</info> and <info type="DiseaseOrPhenotypicFeature">acute lung injury</info>. Characterizing the host cytokine response to RSV infection, the regulation of host cytokines and the impact of neutralizing an RSV-inducible cytokine during infection were undertaken in this study. <info type="DiseaseOrPhenotypicFeature">METHODS</info>: <info type="CellLine">A549</info>, primary human <info type="CellLine">small airway epithelial</info> (<info type="CellLine">SAE</info>) cells and wild-type, <info type="GeneOrGeneProduct">TIR-domain-containing adapter-inducing interferon-b</info> (<info type="GeneOrGeneProduct">Trif</info>) and <info type="GeneOrGeneProduct">mitochondrial antiviral-signaling protein</info> (<info type="GeneOrGeneProduct">Mavs</info>) knockout (<info type="OrganismTaxon">KO</info>) <info type="OrganismTaxon">mice</info> were infected with RSV and cytokine responses were investigated by <info type="GeneOrGeneProduct">ELISA</info>, <info type="GeneOrGeneProduct">multiplex analysis</info> and <info type="GeneOrGeneProduct">qPCR</info>. Neutralizing <info type="ChemicalEntity">anti-leukemia inhibitory factor</info> (<info type="GeneOrGeneProduct">LIF</info>) <info type="ChemicalEntity">IgG</info> or control <info type="ChemicalEntity">IgG</info> was administered to a group of wild-type animals prior to RSV infection. <info type="DiseaseOrPhenotypicFeature">RESULTS AND DISCUSSION</info>: RSV-infected <info type="CellLine">A549</info> and <info type="CellLine">SAE</info> cells release a network of <info type="GeneOrGeneProduct">cytokines</info>, including newly identified RSV-inducible <info type="GeneOrGeneProduct">cytokines</info> <info type="GeneOrGeneProduct">LIF</info>, <info type="GeneOrGeneProduct">migration inhibitory factor</info> (<info type="GeneOrGeneProduct">MIF</info>), <info type="GeneOrGeneProduct">stem cell factor</info> (<info type="GeneOrGeneProduct">SCF</info>), <info type="GeneOrGeneProduct">CCL27</info>, <info type="GeneOrGeneProduct">CXCL12</info> and <info type="GeneOrGeneProduct">stem cell growth factor beta</info> (<info type="GeneOrGeneProduct">SCGF-b</info>). These RSV-inducible <info type="GeneOrGeneProduct">cytokines</info> were also observed in the <info type="OrganismTaxon">airways</info> of <info type="OrganismTaxon">mice</info> during an infection. To identify the regulation of RSV inducible <info type="GeneOrGeneProduct">cytokines</info>, <info type="GeneOrGeneProduct">Mavs</info> and <info type="GeneOrGeneProduct">Trif</info> deficient <info type="OrganismTaxon">animals</info> were infected with RSV. In vivo induction of airway <info type="GeneOrGeneProduct">IL-1b</info>, <info type="GeneOrGeneProduct">IL-4</info>, <info type="GeneOrGeneProduct">IL-5</info>, <info type="GeneOrGeneProduct">IL-6</info>, <info type="GeneOrGeneProduct">IL-12(p40)</info>, <info type="GeneOrGeneProduct">IFN-g</info>, <info type="GeneOrGeneProduct">CCL2</info>, <info type="GeneOrGeneProduct">CCL5</info>, <info type="GeneOrGeneProduct">CCL3</info>, <info type="GeneOrGeneProduct">CXCL1</info>, <info type="GeneOrGeneProduct">IP-10/CXCL10</info>, <info type="GeneOrGeneProduct">IL-22</info>, <info type="GeneOrGeneProduct">MIG/CXCL9</info> and <info type="GeneOrGeneProduct">MIF</info> were dependent on <info type="GeneOrGeneProduct">Mavs</info> expression in <info type="OrganismTaxon">mice</info>. Loss of <info type="GeneOrGeneProduct">Trif</info> expression in <info type="OrganismTaxon">mice</info> altered the RSV induction of <info type="GeneOrGeneProduct">IL-1b</info>, <info type="GeneOrGeneProduct">IL-5</info>, <info type="GeneOrGeneProduct">CXCL12</info>, <info type="GeneOrGeneProduct">MIF</info>, <info type="GeneOrGeneProduct">LIF</info>, <info type="GeneOrGeneProduct">CXCL12</info> and <info type="GeneOrGeneProduct">IFN-g</info>. Silencing of <info type="GeneOrGeneProduct">retinoic acid-inducible gene-1</info> (<info type="GeneOrGeneProduct">RIG-I</info>) expression in <info type="CellLine">A549</info> cells had a greater impact on RSV-inducible <info type="GeneOrGeneProduct">cytokines</info> than <info type="GeneOrGeneProduct">melanoma differentiation-associated protein 5</info> (<info type="GeneOrGeneProduct">MDA5</info>) and <info type="GeneOrGeneProduct">laboratory of genetics and physiology 2</info> (<info type="GeneOrGeneProduct">LGP2</info>), and <info type="GeneOrGeneProduct">Trif</info> expression. To evaluate the role of <info type="GeneOrGeneProduct">LIF</info> in the <info type="OrganismTaxon">airways</info> during <info type="DiseaseOrPhenotypicFeature">RSV infection</info>, <info type="OrganismTaxon">animals</info> were treated with neutralizing <info type="ChemicalEntity">anti-LIF IgG</info>, which enhanced <info type="DiseaseOrPhenotypicFeature">RSV pathology</info> observed with increased <info type="DiseaseOrPhenotypicFeature">airspace protein content</info>, <info type="DiseaseOrPhenotypicFeature">apoptosis</info> and <info type="DiseaseOrPhenotypicFeature">airway hyperresponsiveness</info> compared to control <info type="ChemicalEntity">IgG</info> treatment. <info type="DiseaseOrPhenotypicFeature">CONCLUSIONS</info>: RSV infection in the <info type="OrganismTaxon">epithelium</info> induces a network of immune factors to counter infection, primarily in a <info type="GeneOrGeneProduct">RIG-I</info> dependent manner. Expression of <info type="GeneOrGeneProduct">LIF</info> protects the <info type="OrganismTaxon">lung</info> from <info type="DiseaseOrPhenotypicFeature">lung injury</info> and enhanced pathology during <info type="DiseaseOrPhenotypicFeature">RSV infection</info>.